標(biāo)題: Titlebook: Immunotherapy of Hepatocellular Carcinoma; Tim F. Greten Book 2017 Springer International Publishing AG 2017 Hepatocellular carcinoma.live [打印本頁(yè)] 作者: 恐怖 時(shí)間: 2025-3-21 18:33
書目名稱Immunotherapy of Hepatocellular Carcinoma影響因子(影響力)
書目名稱Immunotherapy of Hepatocellular Carcinoma影響因子(影響力)學(xué)科排名
書目名稱Immunotherapy of Hepatocellular Carcinoma網(wǎng)絡(luò)公開度
書目名稱Immunotherapy of Hepatocellular Carcinoma網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Immunotherapy of Hepatocellular Carcinoma被引頻次
書目名稱Immunotherapy of Hepatocellular Carcinoma被引頻次學(xué)科排名
書目名稱Immunotherapy of Hepatocellular Carcinoma年度引用
書目名稱Immunotherapy of Hepatocellular Carcinoma年度引用學(xué)科排名
書目名稱Immunotherapy of Hepatocellular Carcinoma讀者反饋
書目名稱Immunotherapy of Hepatocellular Carcinoma讀者反饋學(xué)科排名
作者: syncope 時(shí)間: 2025-3-21 23:04 作者: 是他笨 時(shí)間: 2025-3-22 00:39 作者: probate 時(shí)間: 2025-3-22 05:42 作者: DEMN 時(shí)間: 2025-3-22 11:02
Glypican-3 as a Target for Immune Based Therapy in Hepatocellular Carcinoma,ulfate chain. The HN3 and HS20 antibodies inhibit Wnt/Yap signaling and suppress HCC cell growth. To improve anti-tumor efficacy, anti-GPC3 immunotoxins and CAR-T cell therapies have been developed. The Wnt-blocking HN3 immunotoxin is more potent than YP7 immunotoxin. With an engineered toxin, the H作者: 遺忘 時(shí)間: 2025-3-22 15:15
Immune Suppressor Mechanisms in HCC,ytokines as well as cell surface molecules such as PD1/PD-L1 have been described. A better understanding of the immunosuppressive microenvironment in the liver will help better understand the development and growth of HCC and provide opportunities to specifically target mechanism leading to enhanced作者: 調(diào)色板 時(shí)間: 2025-3-22 19:31 作者: Glower 時(shí)間: 2025-3-23 00:44 作者: 自由職業(yè)者 時(shí)間: 2025-3-23 02:34 作者: hermetic 時(shí)間: 2025-3-23 09:01 作者: 熱情贊揚(yáng) 時(shí)間: 2025-3-23 11:35 作者: myocardium 時(shí)間: 2025-3-23 15:30
Eishiro Mizukoshi,Shuichi Kanekoof the contributors encompasses genetics and microbiology, epidemiology, and health economics, as well as clinical cancer prevention. This book will be of interest to all who wish to learn about the most recent progress in combating the development of cancer.978-3-642-26568-6978-3-642-10858-7Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: inquisitive 時(shí)間: 2025-3-23 21:30 作者: 精美食品 時(shí)間: 2025-3-23 23:52
Jeong-Hoon Lee,Jung-Hwan Yoonof the contributors encompasses genetics and microbiology, epidemiology, and health economics, as well as clinical cancer prevention. This book will be of interest to all who wish to learn about the most recent progress in combating the development of cancer.978-3-642-26568-6978-3-642-10858-7Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: ear-canal 時(shí)間: 2025-3-24 04:35 作者: endocardium 時(shí)間: 2025-3-24 07:06
Yi-Fan Zhang,Jessica Hong,Mitchell Hoof the contributors encompasses genetics and microbiology, epidemiology, and health economics, as well as clinical cancer prevention. This book will be of interest to all who wish to learn about the most recent progress in combating the development of cancer.978-3-642-26568-6978-3-642-10858-7Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: 清醒 時(shí)間: 2025-3-24 12:15 作者: 不整齊 時(shí)間: 2025-3-24 18:22
Yeni Ait-Ahmed,Fouad Lafdilof the contributors encompasses genetics and microbiology, epidemiology, and health economics, as well as clinical cancer prevention. This book will be of interest to all who wish to learn about the most recent progress in combating the development of cancer.978-3-642-26568-6978-3-642-10858-7Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: ERUPT 時(shí)間: 2025-3-24 21:47
of the contributors encompasses genetics and microbiology, epidemiology, and health economics, as well as clinical cancer prevention. This book will be of interest to all who wish to learn about the most recent progress in combating the development of cancer.978-3-642-26568-6978-3-642-10858-7Series ISSN 0080-0015 Series E-ISSN 2197-6767 作者: 公共汽車 時(shí)間: 2025-3-25 01:45 作者: GRIN 時(shí)間: 2025-3-25 03:32
liver cancer and tumorimmunology.In this book we provide insights into liver – cancer and immunology. Experts in the field provide an overview over fundamental immunological questions in liver cancer and tumorimmunology, which form the base for immune based approaches in HCC, which gain increasing 作者: 蘑菇 時(shí)間: 2025-3-25 09:18
Antigen-Specific T Cell Responses in Hepatocellular Carcinoma,-to-progression. Further development of immunotherapy in HCC will depend on the identification of highly immunogenic antigen-derived T cell epitopes, such as neoantigens, as well as a better understanding of the mechanisms underlying antitumor immunity.作者: constellation 時(shí)間: 2025-3-25 14:54
Impact of Cytokines in Hepatocellular Carcinoma Initiation and Progression,sion and in therapeutic failures. In addition to curative strategies for HCC, it is of interest to identify and block the immune cell types and their associated cytokines susceptible to trigger tumor initiation and progression作者: 補(bǔ)助 時(shí)間: 2025-3-25 17:08 作者: Robust 時(shí)間: 2025-3-25 23:53
of this text authoritative and comprehensive text are designed to reinforce the principles of about cancer, Cancer Medicine by cancer management and to augment the Holland and Frei, has appeared to explain educational experience. the bridge between this field and the Initially, this book was conceiv作者: 取回 時(shí)間: 2025-3-26 02:50
Maria Tagliamonte,Maria Lina Tornesello,Franco M. Buonaguro,Luigi Buonaguroof this text authoritative and comprehensive text are designed to reinforce the principles of about cancer, Cancer Medicine by cancer management and to augment the Holland and Frei, has appeared to explain educational experience. the bridge between this field and the Initially, this book was conceiv作者: 洞察力 時(shí)間: 2025-3-26 07:19
Elisabetta Cariani,Gabriele Missaleas clinical cancer prevention.Presents the latest advances iThis book is based on presentations by some of the world’s leading experts at the Sixth International Conference on Clinical Cancer Prevention, held in St. Gallen, Switzerland, during March 2010. The main themes are the latest advances in t作者: forbid 時(shí)間: 2025-3-26 11:36 作者: 不感興趣 時(shí)間: 2025-3-26 15:15 作者: 軟膏 時(shí)間: 2025-3-26 17:44
Jeong-Hoon Lee,Jung-Hwan Yoonas clinical cancer prevention.Presents the latest advances iThis book is based on presentations by some of the world’s leading experts at the Sixth International Conference on Clinical Cancer Prevention, held in St. Gallen, Switzerland, during March 2010. The main themes are the latest advances in t作者: 扔掉掐死你 時(shí)間: 2025-3-27 00:04 作者: 者變 時(shí)間: 2025-3-27 01:53
Yi-Fan Zhang,Jessica Hong,Mitchell Hoas clinical cancer prevention.Presents the latest advances iThis book is based on presentations by some of the world’s leading experts at the Sixth International Conference on Clinical Cancer Prevention, held in St. Gallen, Switzerland, during March 2010. The main themes are the latest advances in t作者: 偏離 時(shí)間: 2025-3-27 05:56 作者: Inkling 時(shí)間: 2025-3-27 12:49 作者: 睨視 時(shí)間: 2025-3-27 16:26
as clinical cancer prevention.Presents the latest advances iThis book is based on presentations by some of the world’s leading experts at the Sixth International Conference on Clinical Cancer Prevention, held in St. Gallen, Switzerland, during March 2010. The main themes are the latest advances in t作者: 過去分詞 時(shí)間: 2025-3-27 20:18
Vaccine Approaches in Hepatocellular Carcinoma,h, however, are not strictly specific to HCC. Few of such cancer vaccines have been evaluated in clinical trials which have provided disappointing results. Identification of HCC-associated antigens is required to improve the specificity of the elicited immune response. Furthermore, combinations with作者: 職業(yè) 時(shí)間: 2025-3-28 01:32
Natural Killer Cells in Hepatocellular Carcinoma: Anti-Tumor Effect and Therapeutic Potential,fraction of lymphocytes infiltrating the human liver and they are expected to control hepatocellular carcinoma (HCC) growth at least in the initial phases of tumorigenesis. This has been shown by preclinical data and clinical studies demonstrating association of NK-cell number, cytotoxic phenotype a作者: 殺死 時(shí)間: 2025-3-28 03:13
Antigen-Specific T Cell Responses in Hepatocellular Carcinoma,) and their T cell epitopes for HCC have been identified and studied to understand the immune responses in HCC patients. In addition, these TAAs and epitopes have been used for the development of immunotherapy of HCC. Recent clinical studies using peptide vaccines suggest that, while the efficacy ag作者: 偽造者 時(shí)間: 2025-3-28 07:31
Immune Checkpoint Inhibitors for the Treatment of Hepatocellular Carcinoma,perspective, interaction with checkpoint molecules has revolutionized the field of cancer therapy. Attention has focused in two players, CTLA-4 and PD-1. The former is essential for the activation of CD4+ T cells and the priming phase of the immune response while the latter inhibits CD4+ and CD8+ T 作者: eustachian-tube 時(shí)間: 2025-3-28 12:27 作者: 不公開 時(shí)間: 2025-3-28 15:20
Anti-VEGFR Therapy as a Partner for Immune-Based Therapy Approaches in HCC,ssive cell infiltration (M2-activated macrophages, T regulatory cells and myeloid-derived suppressor cells) and upregulation of immune checkpoints. These immunosuppressive cues lead to impaired effector CD8+ T lymphocyte infiltration and function, and ultimately to immune evasion. Reactivation of th作者: Coronary-Spasm 時(shí)間: 2025-3-28 22:28
Glypican-3 as a Target for Immune Based Therapy in Hepatocellular Carcinoma, GPC3 as an emerging target in various investigational immunotherapies, with a focus on cancer vaccines, human or humanized antibodies, bispecific antibodies, immunotoxins, and chimeric antigen receptor (CAR) T cells. GPC3 peptide-based vaccines have been shown to prevent HCC recurrence after surger作者: fabricate 時(shí)間: 2025-3-28 23:27
Immune Suppressor Mechanisms in HCC, relatively low or can even be discontinued in selected patients over time. Furthermore, the liver is showered with many antigens from the gastrointestinal tract delivered through the portal vein without causing active immune responses. In contrary, tumor-specific immune responses against tumors ari作者: Pruritus 時(shí)間: 2025-3-29 06:28
Impact of Cytokines in Hepatocellular Carcinoma Initiation and Progression,n of many types of cancers, including hepatocellular carcinoma (HCC). Despite considerable progress in HCC diagnosis and improvement of the curative strategies, its incidence is still increasing in western countries and the prognosis of patients with advanced HCC remains in general very poor. Divers作者: Noctambulant 時(shí)間: 2025-3-29 08:32 作者: Notify 時(shí)間: 2025-3-29 14:37
